Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01966978 · ClinicalTrials.gov registry record · Phase 4
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 157
- Enrollment target
NCT01966978 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 157 participants.
The verdict
NCT01966978, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 157 participants
- Enrollment target
Study Summary
The aim of this clinical trial is to assess and compare the effect of insulin detemir in combination with liraglutide and metformin versus insulin detemir in combination with insulin aspart and metformin in subjects with very uncontrolled Type 2 Diabetes (A1c \> 10%).
Interventions
- DRUG Metformin
- DRUG Liraglutide
- DRUG Detemir
- DRUG Insulin Aspart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01966978
The ClinicalTrials.gov registry entry for NCT01966978 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Metformin is the first listed.
NCT01966978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01966978 about?
NCT01966978 is a clinical study titled "The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study". The aim of this clinical trial is to assess and compare the effect of insulin detemir in combination with liraglutide and metformin versus insulin detemir in combination with insulin aspart and metformin in subjects with very uncontrolled Type 2 Diabetes (A1c \> 10%).
What is the current status of trial NCT01966978?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 157 participants. The study started on 2014-11. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01966978?
The interventions under investigation include: Metformin (DRUG), Liraglutide (DRUG), Detemir (DRUG), Insulin Aspart (DRUG).
Who is sponsoring clinical trial NCT01966978?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.